Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06262178 · ClinicalTrials.gov registry record · NA

Parenting STAIR: Adapting a Trauma-Focused Parenting Intervention for Military-Connected Mothers and Their Children

A NA study of Depression and PTSD, sponsored by New York University.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
3
Study locations

NCT06262178: Recruiting NA study of Depression and PTSD, sponsored by New York University.

NCT06262178 is a NA study of Depression and PTSD that is actively recruiting participants, run by New York University. The registered enrollment target is 120 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06262178, a NA study of Depression and PTSD, is actively recruiting participants, sponsored by New York University.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
3
Study locations

Study Summary

The goal of this study is to assess Parenting STAIR Modular (PSTAIR-M), a promising and innovative intervention for military-connected mothers (MCM) who have experienced trauma and their young children (ages 2-10). PSTAIR-M aims to help mothers manage the strong feelings that sometimes happen after experiencing something scary or stressful, as well as to better connect with their children and manage their behavior effectively. The main questions the study aims to answer are: 1) Does PSTAIR-M reduce maternal PTSD and/or depression symptoms?, and 2) Does PSTAIR-M improve parental functioning? Researchers will compare PSTAIR-M to treatment as usual (TAU) - other EBTs offered at participating study sites - to determine if PSTAIR-M is more effective in improving mental health and parenting. Participants will: 1) attend 12-16 weekly, 1-hour online treatment sessions with their assigned clinicians, 2) complete three 1-hour online assessments administered by research staff, 3) engage with their child in three 15-30-minute online, observed play sessions, and 4) have assessments audio and video recorded.

Primary Outcome

The PCL-5 will be used to assess severity and change in PTSD symptoms. The PCL-5 is a 20-item self-report measure with strong evidence of reliability and convergent validity. Participants indicate the degree to which they have been bothered by problems related to a traumatic experience in the past month (e.g., "repeated, disturbing dreams of the stressful experience"; "feeling very upset when something reminded you of the stressful experience") on a 5-point Likert scale (0=not at all; 1=a little

Interventions

  • BEHAVIORAL Parenting-STAIR Modular (PSTAIR-M)
  • BEHAVIORAL Treatment as Usual (TAU)

Study Locations (3)

Texas

  • Steven A. Cohen Military Family Clinic at Endeavors, El Paso - El Paso
  • Steven A. Cohen Military Family Clinic at Endeavors, Killeen - Killeen
  • Steven A. Cohen Military Family Clinic at Endeavors, San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-07-21
Est. Completion 2026-09-30
Phase NA
New York University

83 total trials

What NCT06262178 shows while recruiting

NCT06262178 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (85% lower).

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Parenting-STAIR Modular (PSTAIR-M) is the first listed.

NCT06262178 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06262178 about?

NCT06262178 is a clinical study titled "Parenting STAIR: Adapting a Trauma-Focused Parenting Intervention for Military-Connected Mothers and Their Children". The goal of this study is to assess Parenting STAIR Modular (PSTAIR-M), a promising and innovative intervention for military-connected mothers (MCM) who have experienced trauma and their young children (ages 2-10). PSTAIR-M aims to help mothers manage the strong feelings that sometimes happen after ...

What is the current status of trial NCT06262178?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-07-21. Estimated completion is 2026-09-30.

What conditions does trial NCT06262178 study?

This clinical trial studies the following conditions: Depression, PTSD, Parent-Child Relations.

What interventions are being tested in trial NCT06262178?

The interventions under investigation include: Parenting-STAIR Modular (PSTAIR-M) (BEHAVIORAL), Treatment as Usual (TAU) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06262178?

This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06262178 being conducted?

This trial has 3 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06262178's enrollment target sits among peer trials

120 292nd of 679 higher than 379 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06262178, the US trial registry maintained by the National Library of Medicine. NCT06262178 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.